Inventor
BAILEY JAMES E
CH26 patents
⚠️ This page may combine multiple inventors who share the name “BAILEY JAMES E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ROCHE GLYCART AG
4 patentsUS8021856B2Sep 20, 2011
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
ROCHE GLYCART AG51 citations97
US9321843B2Apr 26, 2016
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
ROCHE GLYCART AG3 citations72
US9718885B2Aug 1, 2017
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
ROCHE GLYCART AG0 citations51
US9631023B2Apr 25, 2017
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
ROCHE GLYCART AG0 citations51
(unassigned)
3 patentsUMAÑA PABLO
3 patentsUS9139654B2Sep 22, 2015
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
UMAÑA PABLO4 citations83
US9068005B2Jun 30, 2015
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
UMAÑA PABLO4 citations83
US8999324B2Apr 7, 2015
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
UMAÑA PABLO4 citations83
GLYCART BIOTECHNOLOGY AG
2 patentsUS6602684B1Aug 5, 2003
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
GLYCART BIOTECHNOLOGY AG1,819 citations98
US7906329B2Mar 15, 2011
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
GLYCART BIOTECHNOLOGY AG50 citations97